Success Metrics

Clinical Success Rate

70.2%

Based on 40 completed trials

Completion Rate

70%(40/57)

Active Trials

11(12%)

Results Posted

50%(20 trials)

Terminated

17(19%)

Phase Distribution

Ph phase_3

30%

Ph early_phase_1

Ph phase_2

19%

Ph phase_4

28%

Ph phase_1

Ph not_applicable

10%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution81 total trials

Early Phase 1First-in-human

2(2.5%)

Phase 1Safety & dosage

1(1.2%)

Phase 2Efficacy & side effects

17(21.0%)

Phase 3Large-scale testing

27(33.3%)

Phase 4Post-market surveillance

25(30.9%)

N/ANon-phased studies

9(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

67.8%

40 of 59 finished

Non-Completion Rate

32.2%

19 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(14)

Completed(40)

Terminated(19)

Other(16)

Detailed Status

Completed40

Terminated17

unknown16

Recruiting10

Not yet recruiting3

Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

70.2%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (2.5%)

Phase 11 (1.2%)

Phase 217 (21.0%)

Phase 327 (33.3%)

Phase 425 (30.9%)

N/A9 (11.1%)

Trials by Status

withdrawn22%

active_not_recruiting11%

recruiting1011%

completed4045%

not_yet_recruiting33%

terminated1719%

unknown1618%

Recent Activity

11 active trials

Showing 5 of 89

recruitingphase_3

Clinical Trials (89)

Showing 20 of 89 trialsScroll for more

NCT07168161Phase 3

BDB-001 Phase III Trial in ANCA-Associated Vasculitis

Recruiting

NCT07271069

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

Recruiting

NCT02939573Phase 2

A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting

NCT07352566Phase 4

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Not Yet Recruiting

NCT00748644Phase 3

Efficacy Study of Two Treatments in the Remission of Vasculitis

Completed

NCT03164473Phase 3

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

Completed

NCT04773392Phase 4

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Terminated

NCT07138898Phase 2

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Not Yet Recruiting

NCT06476366Early Phase 1

Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial

Completed

NCT03414502Phase 3

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Recruiting

NCT07044141Phase 1

Efficacy of Oral Tofacitinib in Combination of Narrow Band UVB in Treatment of Vitiligo

Active Not Recruiting

NCT03681652

Post-Operative Crohn's Disease Outcome in Children

Recruiting

NCT02994927Phase 3

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Completed

NCT00866684Phase 4

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Terminated

NCT04469842Early Phase 1

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Recruiting

NCT06213857Phase 2

Beneficial Effect of Silymarin in Ulcerative Colitis

Recruiting

NCT05349006Phase 3

Azathioprine in MOGAD

Recruiting

NCT04654988Phase 4

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Recruiting

NCT02517684Phase 4

Top-down Infliximab Study in Kids With Crohn's Disease

Completed

NCT05263505Phase 2

Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid

Terminated

Drug Details

Intervention Type: DRUG
Total Trials: 89